Ted Pharmaceuticals generic 4 classes of benzene shun aquco ammonium injection into the administrative approval stage

Pharmaceutical Network December 17th, Beijing Ted Pharmaceuticals to copy the 4 categories of reported benzene shun aquku ammonium injection into the administrative approval stage.
2019, sales of benzene-shun-aqugu ammonium injections in China's public medical institutions exceeded 2.5 billion yuan, up 9.66 percent year-on-year, according to the company's internal network data.
Source: The official website of the State Drug Administration is a medium-effect, non-depolarized, skeletal muscle relaxant with a hetero-phenylate structure, which can be used as an auxiliary drug for whole hemp or as a sedative in the intensive care unit (ICU), which can relax skeletal muscles and make trachea intestor and mechanical flux easy to carry out.
meters of intranet data show that in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) terminal benzene shun aquku ammonium injection sales of more than 2.5 billion yuan, an increase of 9.66 percent year-on-year, the first half of 2020 affected by the epidemic, the growth rate has declined.
Figure: 2020H1 China's public medical institutions terminal benzene shun aquku ammonium injection manufacturer competition pattern source: Mi net China's public medical institutions terminal competition pattern in the first half of 2020 China's public medical institutions terminal benzene shun aku ammonium injection manufacturer competition pattern, Hengrui pharmaceutical dominance is difficult to shake, the market share of more than 70%, the drug Dongying with 16.75 percent of the market share followed.
Table: Benzene Shun Aquku ammonium injection consistency evaluation in review Source: MED2.0 China Drug Review Database Minet data show that currently only Hengrui Pharma submitted a supplementary application for the consistent evaluation of benzene Shun Aquku ammonium injection consistency evaluation, Qilu, Yangzijiang, Beijing Ted Pharmaceuticals and other enterprises to the new classification of production, of which Beijing Ted Pharmaceutical products have entered the administrative approval stage;
source: Mi Net database, state drug regulatory agency official website